FDA Approves First Generic Version of Zocor
The US Food and Drug Administration (Rockville, MD) approved the first generic versions of "Zocor" (simvastatin), the anticholesterol drug by Merck & Co., Inc. (Whitehouse Station, NJ).
The US Food and Drug Administration (Rockville, MD, www.fda.gov) approvedthe first generic version of "Zocor" (simvastatin), the anticholesteroldrug by Merck & Co., Inc. (Whitehouse Station, NJ, www.merck.com).
Simvastatin tablets (5, 10, 20, and 40 mg) are manufactured by IvaxPharmaceuticals, Inc., a wholly owned subsidiary of Teva PharmaceuticalIndustries Limited (Petach Tikva, Israel, www.tevapharm.com).Simvastatin tablets (80 mg) are manufactured by RanbaxyPharmaceuticals, Inc, the US arm of Ranbaxy Laboratories Limited.(Gurgaon, Haryana, India, www.ranbaxy.com).
Merck's US marketing exclusivity for Zocor expired in June 2006. Zocorposted 2005 sales of $4.4 billion, a 16% decline from 2004, as salesoutside of the US were affected by the availability of genericsimvastatin.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
